Page last updated: 2024-09-04

tx 3301 and Atherosclerosis

tx 3301 has been researched along with Atherosclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eisert, C; Fong, A; Hanley, D; Sani, Y; Schevchuck, A; Serebruany, V	1

Trials

1 trial(s) available for tx 3301 and Atherosclerosis

Article	Year
Effects of Aggrenox and aspirin on plasma endothelial nitric oxide synthase and oxidised low-density lipoproteins in patients after ischaemic stroke. The AGgrenox versus aspirin therapy evaluation (AGATE) biomarker substudy. Thrombosis and haemostasis, 2011, Volume: 105, Issue:1 Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Atherosclerosis; Biomarkers; Case-Control Studies; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Humans; Lipoproteins, LDL; Male; Middle Aged; Nitric Oxide Synthase Type III; Pharmacokinetics; Platelet Aggregation Inhibitors; Stroke	2011

Article

Year

Effects of Aggrenox and aspirin on plasma endothelial nitric oxide synthase and oxidised low-density lipoproteins in patients after ischaemic stroke. The AGgrenox versus aspirin therapy evaluation (AGATE) biomarker substudy.

Thrombosis and haemostasis, 2011, Volume: 105, Issue:1

Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Atherosclerosis; Biomarkers; Case-Control Studies; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Humans; Lipoproteins, LDL; Male; Middle Aged; Nitric Oxide Synthase Type III; Pharmacokinetics; Platelet Aggregation Inhibitors; Stroke

2011